相关实验视频

Updated: Jun 17, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

KRAS G12D - - 通过工程外体进行特定向重新编程免疫微环境,使PDAC患者的免疫检查点治疗有效

Valerie S LeBleu, Brandon G Smaglo, Krishnan K Mahadevan

    medRxiv : the preprint server for health sciences
    |March 17, 2025
    PubMed
    概括

    针对KRAS G12D (iExoKras G12D) 的工程外体在早期试验中显示出安全性和胰腺生物分布. 这种胰腺癌治疗增强了抗瘤免疫反应,表明了与免疫治疗的结合潜力.

    更多相关视频

    Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

    Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

    Published on: December 7, 2019

    Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

    Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

    Published on: May 2, 2025

    相关概念视频

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.